Premier Biomedical Stock Probability of Future Pink Sheet Price Finishing Under 7.69E-4
| BIEI Stock | USD 0.0008 0.0001 11.11% |
Premier |
Premier Biomedical Target Price Odds to finish below 7.69E-4
The tendency of Premier Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.0008 or more in 90 days |
| 0.0008 | 90 days | 0.0008 | about 14.63 |
Based on a normal probability distribution, the odds of Premier Biomedical to drop to $ 0.0008 or more in 90 days from now is about 14.63 (This Premier Biomedical probability density function shows the probability of Premier Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Premier Biomedical price to stay between $ 0.0008 and its current price of $8.0E-4 at the end of the 90-day period is roughly 2.92 .
Given the investment horizon of 90 days Premier Biomedical has a beta of -0.31 suggesting as returns on the benchmark increase, returns on holding Premier Biomedical are expected to decrease at a much lower rate. During a bear market, however, Premier Biomedical is likely to outperform the market. Additionally Premier Biomedical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Premier Biomedical Price Density |
| Price |
Predictive Modules for Premier Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Premier Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Premier Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Premier Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Premier Biomedical is not an exception. The market had few large corrections towards the Premier Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Premier Biomedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Premier Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | -0.31 | |
σ | Overall volatility | 0.0003 | |
Ir | Information ratio | -0.04 |
Premier Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Premier Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Premier Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Premier Biomedical generated a negative expected return over the last 90 days | |
| Premier Biomedical has high historical volatility and very poor performance | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. |
Premier Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Premier Pink Sheet often depends not only on the future outlook of the current and potential Premier Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Premier Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 262.1 M |
Premier Biomedical Technical Analysis
Premier Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Premier Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Premier Biomedical. In general, you should focus on analyzing Premier Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Premier Biomedical Predictive Forecast Models
Premier Biomedical's time-series forecasting models is one of many Premier Biomedical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Premier Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Premier Biomedical
Checking the ongoing alerts about Premier Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Premier Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Premier Biomedical generated a negative expected return over the last 90 days | |
| Premier Biomedical has high historical volatility and very poor performance | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. |
Other Information on Investing in Premier Pink Sheet
Premier Biomedical financial ratios help investors to determine whether Premier Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Premier with respect to the benefits of owning Premier Biomedical security.